Literature DB >> 24814339

Squamous cell carcinoma of the parotid gland: a population-based analysis of 2545 cases.

Michael J Pfisterer1, Alejandro Vazquez1, Leila J Mady1, Mohemmed N Khan2, Soly Baredes3, Jean Anderson Eloy4.   

Abstract

PURPOSE: Squamous cell carcinoma (SCC) of the parotid gland is an uncommon tumor, which generally affects older patients. In this study, we explore various aspects of this entity using a national population-based database.
METHODS: The Surveillance, Epidemiology, and End Results (SEER) registry was used to extract data on frequency, incidence, and disease-specific survival (DSS) from 1973 to 2009. Variables analyzed included age, gender, race, histologic grade, stage and treatment. Cox proportional hazards analysis was conducted.
RESULTS: A total of 2545 cases were identified. Parotid SCC was most common in males (79.8%), whites (92.9%), and patients aged ≥75 years (51.4%). Incidence increased slightly over the past three decades (annual percent change 1.90%, p<0.05). Overall 5-year DSS was 54.4%. Statistically significant poor prognostic factors included black race, age ≥75 years, tumor T3 or greater, and higher clinical stage at diagnosis. Elective neck dissection (END) in patients staged N0 was associated with higher DSS (78.3% versus 51.1%, p<0.0001). The omission of END was associated with a three-fold greater hazard of death (hazard ratio 3.19, 95% confidence interval 1.53-7.26, p=0.0016), regardless of whether or not radiotherapy was given.
CONCLUSION: Parotid SCC is uncommon, and data on treatment decisions are limited. Our study profiles the demographic, clinicopathologic, incidence, and survival features of this entity. Perhaps most notably, our results support the practice of END of the N0 neck.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24814339     DOI: 10.1016/j.amjoto.2014.03.003

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  5 in total

1.  The Heterogenicity of Parotid Gland Squamous Cell Carcinoma: A Study of 49 Patients.

Authors:  Achim Franzen; Anja Lieder; Thomas Guenzel; Andre Buchali
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

2.  Nomogram-Based Prediction of Overall and Disease-Specific Survival in Patients With Postoperative Major Salivary Gland Squamous Cell Carcinoma.

Authors:  Lixi Li; Di Zhang; Fei Ma
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

3.  Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period.

Authors:  Michał Żurek; Kamil Jasak; Karolina Jaros; Piotr Daniel; Kazimierz Niemczyk; Anna Rzepakowska
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

4.  High Rates of Ultraviolet-Signature Mutations in Squamous Cell Carcinomas of the Parotid Gland and Prognostic Implications.

Authors:  Shira Fishbach; George Steinhardt; Chao Jie Zhen; Rutika Puranik; Jeremy P Segal; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2021-06-23

5.  Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients.

Authors:  Seung Hee Choi; Jeffrey E Terrell; Karen E Fowler; Scott A McLean; Tamer Ghanem; Gregory T Wolf; Carol R Bradford; Jeremy Taylor; Sonia A Duffy
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.